SCHEMBL12137558

SCHEMBL12137558

Cc1nc(N)nc(-c2ccc3ncccc3c2)c1-c1ccc(N)nc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 7/20 0.51
▸ DYRK1A Q13627 1/20 0.49
▸ NPC1 O15118 1/20 0.47
▸ POLB P06746 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ PIK3CA P42336 3/20 0.43
▸ MTOR P42345 3/20 0.43
▸ SRC P12931 4/20 0.42
▸ PIK3CD O00329 2/20 0.42
▸ ABL1 P00519 2/20 0.42
▸ EGFR P00533 2/20 0.42
▸ HCK P08631 2/20 0.42
▸ KDR P35968 2/20 0.42
▸ PIK3CB P42338 2/20 0.42
▸ PIK3CG P48736 2/20 0.42
▸ EPHB4 P54760 2/20 0.42
▸ PRKDC P78527 2/20 0.42
▸ GRM1 Q13255 2/20 0.42
▸ TGFBR1 P36897 1/20 0.42
▸ TGFBR2 P37173 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12137567 0.91 ALDH1A1 (0.41) ADORA2ADYRK1APIK3CAMTORALDH1A1
SCHEMBL12137964 0.86 TGFBR1 (0.41) ADORA2APIK3CAMTORSRCPIK3CD
SCHEMBL12137958 0.84 KDM4E (0.42) ADORA2APOLBPIK3CAMTORSRC
SCHEMBL12137723 0.81 BACE1 (0.36) ADORA2APIK3CAMTORSRCPIK3CD
SCHEMBL12137956 0.81 PIK3CA (0.44) PIK3CAMTORSRCPIK3CDPIK3CB
SCHEMBL12138120 0.81 BACE1 (0.38) RAB9APIK3CAMTORSRCPIK3CD
SCHEMBL12136155 0.80 MTOR (0.60) ADORA2ADYRK1APIK3CAMTOR
SCHEMBL12137720 0.79 PIK3CA (0.45) ADORA2APIK3CAMTORPIK3CGADORA1
SCHEMBL12137948 0.79 ADORA2A (0.48) ADORA2AMTORABL1KDM4EMAPT
SCHEMBL12137434 0.78 ADORA2A (0.48) ADORA2AATMADORA1BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110281838-A1 5-ALKYNYL-PYRIMIDINES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-11-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110281838-A1 5-ALKYNYL-PYRIMIDINES MKI67, CCNA1, CCNT1 ADORA2A 314/4885DYRK1A 2234/4885NPC1 789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback